Atlas Trials

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Clinical trial NCT00073983 · COMPLETED

Trial details

NCT number
NCT00073983
Sponsor
Sarcoma Alliance for Research through Collaboration
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
2006-10-01
Primary completion
2010-01-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.